omniture
logo
Search
Samsung Biologics Co. Ltd.
Media Room

Photo News

rss
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development

Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development

2024-10-14 19:00 1601
Samsung Biologics launches development platforms for enhanced therapeutic efficacy

Samsung Biologics launches development platforms for enhanced therapeutic efficacy

2024-09-25 19:00 1341
Samsung Biologics obtains three global ISO certifications

Samsung Biologics obtains three global ISO certifications

2022-10-13 19:00 1468
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report

'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report

2022-07-11 19:00 2001
Samsung Biologics holds 11th Annual General Meeting of Shareholders

Samsung Biologics holds 11th Annual General Meeting of Shareholders

2022-03-29 09:42 1947
Samsung Biologics receives 2022 CMO Leadership Award in all six categories

Samsung Biologics receives 2022 CMO Leadership Award in all six categories

2022-02-07 20:00 1998
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea

Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea

2021-12-14 13:34 1586
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

2021-12-14 08:55 1721
Samsung Biologics adds to global ISO certifications with Quality Management System

Samsung Biologics adds to global ISO certifications with Quality Management System

2021-12-07 13:04 1672
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

2021-11-24 20:00 1945
Samsung Biologics Reports Third Quarter 2021 Financial Results

Samsung Biologics Reports Third Quarter 2021 Financial Results

2021-10-26 15:23 1672
Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA

Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA

2021-09-22 18:00 1480
Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

2021-09-13 12:41 1553
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

2021-07-20 20:00 1452
Samsung Biologics Issues Its First Annual Sustainability Report

Samsung Biologics Issues Its First Annual Sustainability Report

2021-06-25 09:01 22574
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections

Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections

2021-06-23 19:28 1389
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

2021-06-02 19:00 1448
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

2021-05-31 19:00 2291
Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management

Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management

2021-05-28 20:00 2766
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

2021-05-23 00:00 8922
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission,

Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life."

2021-04-21 19:00 1584
12